Replimune Group, Inc. — Director's Dealing 2021

Dec 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2021-12-01

Reporting Person: Oliger Christy J. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-01	Stock Option (right to buy)	$28.01	A	33000	Acquired	2031-12-01	Common Stock (33000)	Direct

Footnotes

F1: 25% of the shares underlying this stock option vest on December 1, 2022, and the remainder of the shares underlying this stock option vest in 24 approximately equal monthly installments thereafter.